聯贏激光(688518.SH):光伏和半導體兩家子公司都已經開發出樣機 已開始在客户處進行試用
格隆匯5月7日丨聯贏激光(688518.SH)接受特定對象調研時表示,光伏和半導體兩家子公司去年設立,目前處於隊伍建設、產品研發以及尋找合作伙伴進行產品試用的階段。隊伍的建設、產品研發和合作夥伴開拓比較順利,兩家公司現在都已經開發出樣機,並且已開始在客户處進行試用,兩個子公司公司計劃今年4000萬左右的訂單,隨着產品的進一步成熟,將帶來更大規模的收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.